Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Fitoterapia
- Vol. 124, 42-48
Abstract
No abstract availableKeywords
Funding Information
- University of Padova (CPDA159453)
This publication has 44 references indexed in Scilit:
- Glucose deprivation activates a metabolic and signaling amplification loop leading to cell deathMolecular Systems Biology, 2012
- Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant ResponsesScience, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive ReviewFrontiers in Pharmacology, 2011
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancerCancer and Metastasis Reviews, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 1997
- Statistical analysis of drug-drug and site-site interactions with isobologramsLife Sciences, 1989
- On the Origin of Cancer CellsScience, 1956